149 related articles for article (PubMed ID: 2477560)
21. Brain metastasis as a sole recurrence of prostate cancer after total prostatectomy.
Hayashi T; Igarashi K; Tanizawa A; Terada Y; Sekine H
Urol Int; 1998; 60(2):121-3. PubMed ID: 9563153
[TBL] [Abstract][Full Text] [Related]
22. Prostate-specific antigen level, stage or Gleason score: which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database.
Mithal P; Howard LE; Aronson WJ; Kane CJ; Cooperberg MR; Terris MK; Amling CL; Freedland SJ
Int J Urol; 2015 Apr; 22(4):362-6. PubMed ID: 25728968
[TBL] [Abstract][Full Text] [Related]
23. The results of radical prostatectomy at a community hospital during the prostate specific antigen era.
Smitt MC; Heltzel M
Cancer; 1996 Mar; 77(5):928-33. PubMed ID: 8608486
[TBL] [Abstract][Full Text] [Related]
24. Pattern of failure after radical retropubic prostatectomy for clinically and pathologically localized adenocarcinoma of the prostate: influence of tumor deoxyribonucleic acid ploidy.
Blute ML; Nativ O; Zincke H; Farrow GM; Therneau T; Lieber MM
J Urol; 1989 Nov; 142(5):1262-5. PubMed ID: 2810503
[TBL] [Abstract][Full Text] [Related]
25. Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer.
Stein A; deKernion JB; Smith RB; Dorey F; Patel H
J Urol; 1992 Mar; 147(3 Pt 2):942-6. PubMed ID: 1371565
[TBL] [Abstract][Full Text] [Related]
26. The surgical learning curve for prostate cancer control after radical prostatectomy.
Vickers AJ; Bianco FJ; Serio AM; Eastham JA; Schrag D; Klein EA; Reuther AM; Kattan MW; Pontes JE; Scardino PT
J Natl Cancer Inst; 2007 Aug; 99(15):1171-7. PubMed ID: 17652279
[TBL] [Abstract][Full Text] [Related]
27. Radical prostatectomy and radical radiation therapy for clinical stages T1 to 2 adenocarcinoma of the prostate: new insights into outcome from repeat biopsy and prostate specific antigen followup.
Zietman AL; Shipley WU; Coen JJ
J Urol; 1994 Nov; 152(5 Pt 2):1806-12. PubMed ID: 7523726
[TBL] [Abstract][Full Text] [Related]
28. The incidence of prostate cancer progression with undetectable serum prostate specific antigen in a series of 394 radical prostatectomies.
Oefelein MG; Smith N; Carter M; Dalton D; Schaeffer A
J Urol; 1995 Dec; 154(6):2128-31. PubMed ID: 7500474
[TBL] [Abstract][Full Text] [Related]
29. Do Ultrasensitive Prostate Specific Antigen Measurements Have a Role in Predicting Long-Term Biochemical Recurrence-Free Survival in Men after Radical Prostatectomy?
Sokoll LJ; Zhang Z; Chan DW; Reese AC; Bivalacqua TJ; Partin AW; Walsh PC
J Urol; 2016 Feb; 195(2):330-6. PubMed ID: 26307160
[TBL] [Abstract][Full Text] [Related]
30. Correlation of prostate-specific acid phosphatase and prostate-specific antigen immunocytochemistry with survival in prostate carcinoma.
Hammond ME; Sause WT; Martz KL; Pilepich MV; Asbell SO; Rubin P; Myers RP; Farrow GM
Cancer; 1989 Feb; 63(3):461-6. PubMed ID: 2463874
[TBL] [Abstract][Full Text] [Related]
31. Impact of patient age on biochemical recurrence rates following radical prostatectomy.
Magheli A; Rais-Bahrami S; Humphreys EB; Peck HJ; Trock BJ; Gonzalgo ML
J Urol; 2007 Nov; 178(5):1933-7; discussion 1937-8. PubMed ID: 17868723
[TBL] [Abstract][Full Text] [Related]
32. Urethral metastasis from prostatic carcinoma as diagnosed by immunoperoxidase technique using prostate-specific antigen and prostate-specific acid phosphatase.
Koh E; Sekii K; Namiki M; Fujioka H; Onoue K; Sakurai M; Sonoda T
Eur Urol; 1987; 13(1-2):142-4. PubMed ID: 2438138
[TBL] [Abstract][Full Text] [Related]
33. Prostate specific antigen and local recurrence after radical prostatectomy.
Lightner DJ; Lange PH; Reddy PK; Moore L
J Urol; 1990 Oct; 144(4):921-6. PubMed ID: 1697917
[TBL] [Abstract][Full Text] [Related]
34. The ratio of oleic-to-stearic acid in the prostate predicts biochemical failure after radical prostatectomy for localized prostate cancer.
Kositsawat J; Flanigan RC; Meydani M; Choi YK; Freeman VL
J Urol; 2007 Dec; 178(6):2391-6; discussion 2396. PubMed ID: 17936811
[TBL] [Abstract][Full Text] [Related]
35. Radical prostatectomy for clinical stage T3a disease.
Freedland SJ; Partin AW; Humphreys EB; Mangold LA; Walsh PC
Cancer; 2007 Apr; 109(7):1273-8. PubMed ID: 17315165
[TBL] [Abstract][Full Text] [Related]
36. Ultrasensitive prostate specific antigen and its role after radical prostatectomy: a systematic review.
Tilki D; Kim SI; Hu B; Dall'Era MA; Evans CP
J Urol; 2015 May; 193(5):1525-31. PubMed ID: 25444980
[TBL] [Abstract][Full Text] [Related]
37. Accuracy of predicting long-term prostate specific antigen outcome based on early prostate specific antigen recurrence results after radical prostatectomy.
Soergel TM; Koch MO; Foster RS; Bihrle R; Wahle G; Gardner T; Jung SH
J Urol; 2001 Dec; 166(6):2198-201. PubMed ID: 11696735
[TBL] [Abstract][Full Text] [Related]
38. Clinical and molecular followup after radical retropubic prostatectomy.
Oefelein MG; Ignatoff JM; Clemens JQ; Watkin W; Kaul KL
J Urol; 1999 Aug; 162(2):307-10; discussion 310-1. PubMed ID: 10411026
[TBL] [Abstract][Full Text] [Related]
39. Vascular invasion predicts recurrence after radical prostatectomy: stratification of risk based on pathologic variables.
Ferrari MK; McNeal JE; Malhotra SM; Brooks JD
Urology; 2004 Oct; 64(4):749-53. PubMed ID: 15491714
[TBL] [Abstract][Full Text] [Related]
40. An analysis of urinary prostate specific antigen before and after radical prostatectomy: evidence for secretion of prostate specific antigen by the periurethral glands.
Iwakiri J; Granbois K; Wehner N; Graves HC; Stamey T
J Urol; 1993 Apr; 149(4):783-6. PubMed ID: 7681118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
